Sign In

Kimberly Cockerham

Ophthalmic Surgeon | Neuro-Ophthalmology, Orbital Disease and Oculofacial Restoration

Kimberly Cockerham, MD, FACS, is an accomplished ophthalmic surgeon affiliated with Sharp HealthCare. She has a distinguished career in ophthalmology, specializing in neuro-ophthalmology, thyroid eye disease, and orbital diseases. Cockerham is also recognized for her work in facial plastics and strabismus.

Professional Background

  • Current Roles:

    • Ophthalmic Surgeon at Sharp HealthCare.
    • Adjunct Clinical Associate Professor at Stanford University Medical Center, where she mentors residents and coordinates educational courses.
    • Founder of "Let's Face It Together," an initiative aimed at assisting patients with medical issues navigate the healthcare system.
  • Leadership Positions:

    • Currently serving as the president of the California Academy of Eye Physicians and Surgeons.
    • A councilor with the American Academy of Ophthalmology (AAO) since 2007, where she has advocated for telemedicine in ophthalmology.

Experience

Cockerham has extensive clinical experience, having founded Cockerham Eye Consultants in 2006. Her practice has expanded to multiple locations in California. She has also held significant positions such as Director of Ophthalmic Plastics and Reconstruction at UCSF and has served as a consultant in neuro-ophthalmology.

Education and Recognition

Cockerham is a decorated veteran and has been practicing medicine for over 25 years. Her contributions to the field have been recognized through various awards and leadership roles within professional organizations.

Her commitment to patient care and education reflects her passion for the field of ophthalmology, making her a prominent figure in her specialty.

Highlights

Jun 27 · linkedin

Btw that last post was an AI rewrite, interesting style - but not me.

Jun 25 · linkedin

🔬 Exciting Updates in Clinical Trials! 🔬

🔹 Viridian Strive clinical trial is currently seeking Thyroid Eye Disease (TED) adult subjects! Eligible individuals can refer via the chat function on CockerhamMD.com for an intravenous dose of either 3 or 10 mg. Notably, there is no placebo arm for this trial.

🔹 Horizon/Amgen has successfully recruited their first subject for a clinical trial focusing on the transcutaneous delivery of a modified Tepezza molecule. The randomized process for this study is set to commence on July 9th.

🔹 In another recent development, the Genentech/Roche clinical trial is now live, with a primary focus on evaluating the efficacy of an IL6 monoclonal antibody.

Stay tuned for more updates on these groundbreaking clinical trials! 🌟 #ClinicalTrials #Healthcare #MedicalResearch

Related Questions

What are Kimberly Cockerham's main specialties in ophthalmology?
How has Kimberly Cockerham contributed to the American Academy of Ophthalmology?
What is the mission of "Let's Face It Together" founded by Kimberly Cockerham?
Where are Kimberly Cockerham's primary practice locations?
What is Kimberly Cockerham's role at Stanford University Medical Center?
Kimberly Cockerham
Kimberly Cockerham, photo 1
Kimberly Cockerham, photo 2
Add to my network

Location

San Diego, California, United States